Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)
Clinical trial NCT00729183 · COMPLETED
Trial details
- NCT number
- NCT00729183
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-02
- Primary completion
- 2010-03-23
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.